We are live on ! Find out more
CCM

Copernicus Capital Management Portfolio holdings

AUM $8.26M
1-Year Est. Return 37.91%
This Fund
S&P 500
This Quarter Est. Return
+7.63%
1 Year Est. Return
+37.91%
3 Year Est. Return
+125.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$138M
AUM Growth
+$12.3M
Cap. Flow
+$4.82M
Cap. Flow %
3.5%
Top 10 Hldgs %
70.81%
Holding
25
New
5
Increased
12
Reduced
2
Closed
6

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$8.94M
2
HOLX
Hologic
HOLX
+$6.52M
3
HSIC icon
Henry Schein
HSIC
+$3.95M
4
IART icon
Integra LifeSciences
IART
+$3.9M
5
EW icon
Edwards Lifesciences
EW
+$3.9M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$9.23M
2
BIIB icon
Biogen
BIIB
+$9.12M
3
GILD icon
Gilead Sciences
GILD
+$8.78M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$5.57M
5
MOH icon
Molina Healthcare
MOH
+$4.94M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYK icon
1
Stryker
SYK
$122B
$11.9M 8.6%
70,209
+18,200
+35% +$3.06M
TMO icon
2
Thermo Fisher Scientific
TMO
$213B
$11.5M 8.37%
55,645
+11,645
+26% +$2.47M
ISRG icon
3
Intuitive Surgical
ISRG
$119B
$11.5M 8.36%
72,219
+1,455
+2% +$222K
ILMN icon
4
Illumina
ILMN
$29.8B
$11.5M 8.34%
42,275
+1,692
+4% +$430K
VRTX icon
5
Vertex Pharmaceuticals
VRTX
$120B
$11.3M 8.2%
66,440
+14,196
+27% +$2.2M
DVA icon
6
DaVita
DVA
$15B
$9.55M 6.93%
137,496
+43,370
+46% +$2.9M
CVS icon
7
CVS Health
CVS
$136B
$8.73M 6.33%
+135,595
New +$8.94M
EW icon
8
Edwards Lifesciences
EW
$48.3B
$8.44M 6.13%
174,000
+83,526
+92% +$3.9M
HOLX
9
DELISTED
Hologic
HOLX
$6.74M 4.89%
+169,511
New +$6.52M
CLVS
10
DELISTED
Clovis Oncology, Inc.
CLVS
$6.43M 4.66%
141,345
+70,253
+99% +$3.42M
FOLD
11
DELISTED
Amicus Therapeutics
FOLD
$5.82M 4.23%
372,798
-2,572
-0.7% -$38.9K
HRTX icon
12
Heron Therapeutics
HRTX
$86.9M
$5.61M 4.07%
144,382
+36,382
+34% +$1.16M
ARRY
13
DELISTED
Array Biopharma Inc
ARRY
$4.81M 3.49%
286,797
+155,379
+118% +$2.47M
ZTS icon
14
Zoetis
ZTS
$31.3B
$4.76M 3.46%
55,905
+214
+0.4% +$18.1K
NUVA
15
DELISTED
NuVasive, Inc.
NUVA
$4.58M 3.33%
87,906
+337
+0.4% +$17.7K
IART icon
16
Integra LifeSciences
IART
$1.44B
$4.06M 2.95%
+63,000
New +$3.9M
HSIC icon
17
Henry Schein
HSIC
$9.63B
$4M 2.9%
+70,125
New +$3.95M
MOH icon
18
Molina Healthcare
MOH
$10.5B
$3.6M 2.61%
36,737
-56,645
-61% -$4.94M
HUM icon
19
Humana
HUM
$47.4B
$2.98M 2.16%
+10,000
New +$2.93M
BIIB icon
20
Biogen
BIIB
$29.6B
– –
-33,296
Closed -$9.12M
CI icon
21
Cigna
CI
$75.7B
– –
-55,000
Closed -$9.23M
GILD icon
22
Gilead Sciences
GILD
$162B
– –
-116,506
Closed -$8.78M
SCI icon
23
Service Corp International
SCI
$10.9B
– –
-92,796
Closed -$3.5M
ALXN
24
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-50,000
Closed -$5.57M
CELG
25
DELISTED
Celgene Corp
CELG
– –
-28,100
Closed -$2.51M

Similar funds

AAM
Areion Asset Management Hong Kong $7.82M AUM 16% 1-Year Est. Return
IR
Invictus RG Hamilton, Bermuda $8.9M AUM 56.32% 1-Year Est. Return
YEPV
Yorktown Energy Partners VI New York $6.21M AUM 74.4% 1-Year Est. Return
LC
Lunia Capital Dallas, Texas $4.49M AUM 42.82% 1-Year Est. Return
MA
MANA Advisors New York $3.06M AUM 7.13% 1-Year Est. Return
IFC
Intact Financial Corporation Toronto, Ontario, Canada $14M AUM
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Copernicus Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Copernicus Capital Management held 25 positions worth $138M, up 9.8% from $125M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Copernicus Capital Management deployed $4.82M of net new capital in Q2 2018, opening 5 new positions and adding to 12 existing holdings. Its largest new stake was CVS Health: 135,595 shares worth $8.73M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 97% a quarter earlier, followed by Consumer Discretionary.

On the sell side, the largest reduction was Molina Healthcare, an estimated $4.94M trimmed.

  • Copernicus Capital Management's largest Q2 2018 buy was CVS Health: 135,595 shares worth $8.73M.
  • Copernicus Capital Management added most to Edwards Lifesciences in Q2 2018, an estimated $3.9M increase.
  • Copernicus Capital Management's biggest Q2 2018 reduction was Molina Healthcare, cutting an estimated $4.94M.
  • Copernicus Capital Management fully exited Cigna in Q2 2018, selling an estimated $9.23M.
  • Copernicus Capital Management's ten largest holdings make up 71% of its $138M portfolio in Q2 2018.
  • Copernicus Capital Management opened 5 new positions and closed 6 in Q2 2018.
  • Copernicus Capital Management's portfolio value rose 9.8% quarter-over-quarter to $138M.

Based on Copernicus Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.